| Serial Number | 97267309 |
| Word Mark | BLUDIGO |
| Filing Date | Tuesday, February 15, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 2, 2024 |
| Registration Number | 7347784 |
| Registration Date | Tuesday, April 2, 2024 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 7, 2023 |
| Goods and Services | Pharmaceutical preparations in the nature of indigo carmine solutions for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; chemical preparations in the nature of indigo carmine for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; chemical preparations in the nature of indigo carmine solutions for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; indigo carmine solutions for use as a marker during gastro-intestinal endoscopy; indigo carmine solutions used as a contrast solution for medical imaging procedures; indigo carmine solutions for medical diagnostic purposes for viewing and marking tissue; indigo carmine solutions used as an aid in visualization of topographic irregularities and in delineation of polypoid or flat lesions, including adenomas; indigo carmine solutions used for polyps or lesions resection medicines for tissue staining; indigo carmine solutions for use as a marker during visceral surgery; indigo carmine solutions for the detection of amniotic fluid leaks; indigo carmine solutions for use as a marker during cystoscopy and ureteral catheterization; indigo carmine solutions for use as a marker during vessel delineation and tumor localization procedures; clinical medical reagents; diagnostic preparations in vials for medical use; drug delivery agents in the form of filled vials that facilitate the delivery of pharmaceutical preparations |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 18, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, September 23, 2022 |
| First Use In Commerce Date | Friday, September 23, 2022 |
| Party Name | PROVEPHARM LIFE SOLUTIONS |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Marseille 13013 FR |
| Party Name | PROVEPHARM LIFE SOLUTIONS |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Marseille 13013 FR |
| Party Name | PROVEPHARM LIFE SOLUTIONS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Marseille 13013 FR |
| Event Date | Event Description |
| Tuesday, April 2, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, April 2, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, February 29, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, February 28, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, February 27, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 27, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 27, 2024 | ASSIGNED TO LIE |
| Thursday, October 5, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 16, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 16, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, August 16, 2023 | SU - NON-FINAL ACTION - WRITTEN |
| Wednesday, June 7, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, May 11, 2023 | USE AMENDMENT FILED |
| Monday, June 5, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, May 11, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, April 4, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 7, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 7, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 18, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, December 30, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 30, 2022 | ASSIGNED TO EXAMINER |
| Friday, February 18, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 18, 2022 | NEW APPLICATION ENTERED |